Mako Surgical Corp: (NASD: MAKO)

$10.91

-0.60 (-5.21%)

Volume 673,105

May 22 03:25 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		10.91 - 11.90
	
		52wk Low - High
		10.00 - 27.18
	
		Previous Close
		11.51
	
		Avg. Volume
		1,054,381
	
		Industry
		MED INSTRUMENTS
	
		Market Cap
		543.47 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.48
	
		PE (Forward)
		0.00
	
		Current Year Est.
		-0.60
	
		Quarterly Earnings ESP 
		-28.57%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		113 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/9/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            NA
                        
                            PEG Ratio
                            NA
                        
                            Current Year Est.
                            -0.60
                        
                            Current Quarter Estimate
                            -0.21
                        
                            Most Accurate Estimate
                            -0.27
                        
                            Earnings ESP 
                            -28.57%
                        
                            Next Earnings Report Date
                            08-07-2013
                        
                            EPS Last Year
                            -0.69
                        
                            Expected Earnings Growth
                            20.00%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
MAKO SURGICAL CORP. is a medical device company that markets its advanced robotic-arm solution and implants for minimally invasive orthopedic knee procedures. MAKO's Tactile Guidance System includes an interactive tactile robotics-arm platform that utilizes tactile-guided robotics and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a keyhole incision. This FDA-cleared surgeon-interactive tactile robotic-arm system allows surgeons to provide an innovative tissue-sparing bone resurfacing therapy called MAKOplasty to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications relating to the areas of computer assisted surgery, haptics, robotics, and implants.   
Full MAKO Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
MAKO Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	-0.21	-0.11	-0.60	-0.24
Number of Estimates	6	6	7	7
Low Estimate	-0.29	-0.13	-0.73	-0.42
High Estimate	-0.12	-0.08	-0.42	NA
Year Ago EPS	-0.20	-0.15	-0.76	-0.60
EPS Growth	-5.83%	26.67%	21.62%	59.47%

More MAKO Estimates

Average Earnings Estimates for MAKO

EPS Growth for MAKO

Industry Analysis

Name	Symbol	Previous Close
MAKO SURGICAL	MAKO	11.51
NATUS MEDICAL	BABY	15.11
CRYOLIFE INC	CRY	6.49
DELCATH SYS INC	DCTH	0.44
GLOBUS MEDICAL	GMED	15.82
HEARTWARE INTL	HTWR	95.05
INTUITIVE SURG	ISRG	485.88
MELA SCIENCES	MELA	1.09
OXYSURE SYSTEMS	OXYS	0.82
PACIFIC BIOSCI	PACB	2.54

Sector:Medical>> Industry:MED INSTRUMENTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Accuray Lags 3Q Earnings Est

May 08, 2013

Accuray Lags 3Q Earnings Est

May 08, 2013

Cepheid Unveils Prelim 4Q Results

Jan 10, 2013

MAKO Surgical Corp. Enters Oversold Territory

Jan 09, 2013

Secondary Offering by MAKO

Nov 14, 2012

Bearish MACD for MAKO Surgical Corp.

Jul 27, 2012

Bearish MACD for MAKO Surgical Corp

Jul 13, 2012

MAKO Reports Selected 2Q Results

Jul 10, 2012

More MAKO Zacks Commentary

Financials

EPS TTM	-0.69
Sales	103
Net Income	-30
Price/Earnings	NA
Price/Book	4.00
Price/Cash Flow	NA
Price/Sales	5.04

More MAKO Financials

News

One Way MAKO Surgical Could Quadruple - TheMotleyFool

May 22, 2013

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago MAKO Surgical Is Up 7.0% (MAKO) - Comtex Smartrend(R)

May 20, 2013

MAKO Surgical Notches Another Legal Victory - TheMotleyFool

May 20, 2013

MAKO Surgical Q1 net loss decreases - Datamonitor

May 20, 2013

Stock Investors Bid Up Shares of MAKO Surgical, Up 3.0% - Financial News Network Online - Market Movers

May 20, 2013

Post Earnings Update: MAKO Surgical Has Climbed 7.0% Higher in Past Week (MAKO) - Financial News Network Online - Earnings Lookback

May 18, 2013

Buyers Accumulate Shares of MAKO Surgical, Up 3.4% - Financial News Network Online - Market Movers

May 16, 2013

MAKO Surgical Shares Climbing Higher, Up 1.8% - Financial News Network Online - Market Movers

May 13, 2013

See All News Stories on MAKO

Broker Recommendations

Current ABR	2.43
ABR (Last Week)	2.43
# of recs in ABR	7
Average Target Price	15.00
Industry Rank by ABR	113 out of 265
Rank in Industry	11 out of 54

More MAKO Broker Recommendations

Day Low - High	10.91 - 11.90
52wk Low - High	10.00 - 27.18
Previous Close	11.51
Avg. Volume	1,054,381
Industry	MED INSTRUMENTS
Market Cap	543.47 M
Div - Yield	0.00 - 0.00
Beta	0.48
PE (Forward)	0.00
Current Year Est.	-0.60
Quarterly Earnings ESP	-28.57%

PE (Forward)	NA
PEG Ratio	NA
Current Year Est.	-0.60
Current Quarter Estimate	-0.21
Most Accurate Estimate	-0.27
Earnings ESP	-28.57%
Next Earnings Report Date	08-07-2013
EPS Last Year	-0.69
Expected Earnings Growth	20.00%

Username: Password:

Remember me [?]

Mako Surgical Corp: (NASD: MAKO)

$10.91

-0.60 (-5.21%)

Volume 673,105

May 22 03:25 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED INSTRUMENTS

Zacks Commentary

Financials

News

Broker Recommendations